Company Valuation: Boston Scientific Corporation

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Capitalization 1 60,534 66,273 84,691 131,642 141,351 83,117 - -
Change - 9.48% 27.79% 55.44% 7.37% -41.2% - -
Enterprise Value (EV) 1 67,674 74,280 92,928 141,974 150,822 89,411 86,016 82,015
Change - 9.76% 25.1% 52.78% 6.23% -40.72% -3.8% -4.65%
P/E ratio 61.6x 103x 54x 71.5x 49.1x 20.6x 19.5x 17.1x
PBR 3.64x 3.77x 4.39x 6.05x 5.84x 2.95x 2.62x 2.33x
PEG - -3x 0x 4.3x 0.9x 0.5x 3.39x 1.2x
Capitalization / Revenue 5.09x 5.23x 5.95x 7.86x 7.04x 3.83x 3.53x 3.25x
EV / Revenue 5.69x 5.86x 6.53x 8.48x 7.51x 4.12x 3.65x 3.2x
EV / EBITDA 16.5x 20.8x 22.6x 29.3x 25.3x 13.4x 11.6x 10x
EV / EBIT 22.5x 22.9x 24.9x 31.3x 26.9x 14.5x 12.7x 10.9x
EV / FCF 51.4x 79.2x 51.9x 53.7x 41.2x 21.3x 20.4x 15.4x
FCF Yield 1.94% 1.26% 1.93% 1.86% 2.43% 4.7% 4.9% 6.5%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 0.69 0.45 1.07 1.25 1.94 2.711 2.867 3.273
Distribution rate - - - - - - - -
Net sales 1 11,888 12,682 14,240 16,747 20,074 21,681 23,569 25,607
EBITDA 1 4,103 3,574 4,106 4,839 5,973 6,683 7,394 8,199
EBIT 1 3,010 3,241 3,738 4,529 5,612 6,173 6,795 7,526
Net income 1 985 642 1,570 1,853 2,898 3,924 4,169 4,801
Net Debt 1 7,140 8,007 8,237 10,332 9,471 6,294 2,899 -1,102
Reference price 2 42.48 46.27 57.81 89.32 95.35 55.92 55.92 55.92
Nbr of stocks (in thousands) 1,424,992 1,432,311 1,464,983 1,473,827 1,482,442 1,486,355 - -
Announcement Date 2/2/22 2/1/23 1/31/24 2/5/25 2/4/26 - - -
1USD in Million2USD
Estimates

P/E ratio, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
20.63x4.12x13.38x-.--% 83.12B
21.98x4.08x15.74x0.42% 164B
48.31x12.66x28.37x-.--% 156B
25.98x4.91x15.3x0.91% 116B
29.38x6.54x20.7x-.--% 47.44B
17.73x2.06x10.53x2.96% 43.71B
35.47x5.71x17.42x-.--% 32.62B
21.5x4.41x15.29x0.91% 31.68B
19.27x5.08x12.78x1.19% 29.61B
21.86x4.7x14.65x2.87% 27.77B
Average 26.21x 5.43x 16.41x 0.93% 73.2B
Weighted average by Cap. 28.76x 6.23x 17.99x 0.61%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. BSX Stock
  4. Valuation Boston Scientific Corporation